Marc Barry, MD

Associate Professor, University of Utah School of Medicine

Specialties

• Renal pathology
• Genitourinary

Education

• Medical Degree—University College Dublin
• Residency—Anatomic Pathology, Brigham and Women’s Hospital
• Research Fellowship—Massachusetts Institute of Technology
• Fellowship—Medical Renal Pathology, Brigham and Women’s Hospital
• Fellowship—Urologic Pathology, Brigham and Women’s Hospital

Certifications/Affiliations

• American Board of Pathology
• United States and Canadian Academy of Pathology
• American Society for Clinical Pathology
• College of American Pathologists

Research Interests

• Clinicopathologic questions in medical renal and urologic pathology
• Epidemiologic and translational aspects of urologic neoplasia

Awards

• Registrar’s Prize for Research from the Royal Academy of Medicine in Ireland, 2000
• Research Scholarship Award from the College of American Pathology Foundation, 2004
• Prize from the journal “Urology” for the best paper in 2007 by a resident or fellow, 2008
• Formally recognized for “Excellence in Urologic Resident Education” by the Division of Urology, University of New Mexico School of Medicine, 2014

Recent Publications

• Berggren KL, et al. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma. Oncogene. 2019 Nov;38(48):7329–41.
• Nash SH, et al. Cancer survival among Alaska Native people. Cancer. 2018 Jun 15;124(12):2570–7.
• Hill DA, et al. Breast cancer survival, survival disparities, and guideline-based treatment. Breast Cancer Res Treat. 2018 Jul;170(2):40–14.
• Hill DA, et al. Estrogen receptor quantitative measures and breast cancer survival. Breast Cancer Res Treat. 2017 Dec;166(3): 855–64.
• Teixeira AA, et al. Going viral? Linking the etiology of human prostate cancer to the PCA3 long noncoding RNA and oncogenic viruses. EMBO Mol Med. 2017 Oct 9(10):1327–30.
• Ferrara F, et al. Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer. Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):12786–91.
• Dobroff AS, et al. Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes. Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):12780–5.
• Vigil D, et al. BK nephropathy in the native kidneys of patients with organ transplants: clinical spectrum of BK infection. World J Transplant, 2016 Sept 24;6(3):472–504.
• Reynolds S, et al. A case of primary mammary analog secretory carcinoma (MASC) of the thyroid masquerading as papillary thyroid carcinoma: potentially more than a one off. Head Neck Pathol. 2016 Sept;10(3):405–13.
• Hoffman RM, et al. Trends in United States prostate cancer incidence rates by age and stage, 1995–2012. Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):259–63.